Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer
Baozhen Ma(Henan Cancer Hospital), Quanli Gao(Zhengzhou University), Hao Huang(Zhengzhou University), Zibing Wang(Huazhong University of Science and Technology), Xiaomin Fu(Zhengzhou University), Jindong Guo(Henan Cancer Hospital), Lingdi Zhao(Zhengzhou University), Hongwei Lin(Zhengzhou University), Yonghao Yang(Army Medical University), Fang Zhang(Henan Cancer Hospital), Yong Zhang(Lanzhou University), Yu Zhou(Zhengzhou University), Benling Xu(Zhengzhou University), Mengyuan Zhou(Soochow University), Fanghui Li(Zhengzhou University), Yiman Shang(Henan Cancer Hospital)
Cited by 5
Related Papers
Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
|Science Immunology|2020|555
IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor
|Nature Immunology|2021|374
A Molecular Foaming and Activation Strategy to Porous N-Doped Carbon Foams for Supercapacitors and CO2 Capture
|Nano-Micro Letters|2020|83